13F HOLDINGS REPORT
Casdin Capital, LLC
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0000919574-24-006736
Total Value
$1.50B
Positions
35
Other Managers
0
Confidential Omitted
No
Holdings (35)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BIOLIFE SOLUTIONS INC | BLFS | 8,707,165 | $218.0M | 14.54% |
| 2 | REVOLUTION MEDICINES INC | RVMDW | 4,114,283 | $186.6M | 12.44% |
| 3 | GENEDX HOLDINGS CORP | WGSWW | 3,507,164 | $148.8M | 9.92% |
| 4 | STANDARD BIOTOOLS INC | LAB | 71,254,677 | $137.5M | 9.17% |
| 5 | SAREPTA THERAPEUTICS INC | SRPT | 1,073,500 | $134.1M | 8.94% |
| 6 | ILLUMINA INC | ILMN | 750,000 | $97.8M | 6.52% |
| 7 | AVIDITY BIOSCIENCES INC | 05370A108 | 2,084,841 | $95.8M | 6.38% |
| 8 | RELAY THERAPEUTICS INC | RLAY | 9,251,108 | $65.5M | 4.37% |
| 9 | ALNYLAM PHARMACEUTICALS INC | ALNY | 170,000 | $46.8M | 3.12% |
| 10 | EXACT SCIENCES CORP | 30063P105 | 650,000 | $44.3M | 2.95% |
| 11 | INTELLIA THERAPEUTICS INC | NTLA | 2,000,000 | $41.1M | 2.74% |
| 12 | STRUCTURE THERAPEUTICS INC | GPCR | 700,000 | $30.7M | 2.05% |
| 13 | BLUEPRINT MEDICINES CORP | 09627Y109 | 326,378 | $30.2M | 2.01% |
| 14 | DENALI THERAPEUTICS INC | DNLI | 990,000 | $28.8M | 1.92% |
| 15 | CODEXIS INC | CDXS | 8,100,000 | $24.9M | 1.66% |
| 16 | VERACYTE INC | VCYT | 666,308 | $22.7M | 1.51% |
| 17 | NEUROGENE INC | NGNE | 524,616 | $22.0M | 1.47% |
| 18 | VERVE THERAPEUTICS INC | 92539P101 | 3,995,571 | $19.3M | 1.29% |
| 19 | BEAM THERAPEUTICS INC | BEAM | 775,000 | $19.0M | 1.27% |
| 20 | TENAYA THERAPEUTICS INC | TNYA | 6,732,971 | $13.0M | 0.87% |
| 21 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 1,150,000 | $12.4M | 0.83% |
| 22 | 2SEVENTY BIO INC | 901384107 | 2,000,000 | $9.4M | 0.63% |
| 23 | TANGO THERAPEUTICS INC | TNGX | 1,188,349 | $9.2M | 0.61% |
| 24 | SYNDAX PHARMACEUTICALS INC | SNDX | 475,000 | $9.1M | 0.61% |
| 25 | GUARDANT HEALTH INC | GH | 350,000 | $8.0M | 0.54% |
| 26 | CONTINEUM THERAPEUTICS INC | CTNM | 296,666 | $5.7M | 0.38% |
| 27 | CENTURY THERAPEUTICS INC | IPSC | 3,212,316 | $5.5M | 0.37% |
| 28 | GRAIL INC | GRAL | 350,000 | $4.8M | 0.32% |
| 29 | ABSCI CORPORATION | ABSI | 973,260 | $3.7M | 0.25% |
| 30 | PACIFIC BIOSCIENCES CALIF IN | 69404D108 | 1,035,859 | $1.8M | 0.12% |
| 31 | PRIME MEDICINE INC | PRME | 367,175 | $1.4M | 0.09% |
| 32 | EXSCIENTIA PLC | 30223G102 | 213,900 | $1.0M | 0.07% |
| 33 | MONTE ROSA THERAPEUTICS INC | GLUE | 86,014 | $455,874 | 0.03% |
| 34 | GINKGO BIOWORKS HOLDINGS INC | DNABW | 36,493 | $297,418 | 0.02% |
| 35 | KRONOS BIO INC | 50107A104 | 123,839 | $123,827 | 0.01% |